Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

pSivida Corp (NASDAQ:PSDV)

1.37
Delayed Data
As of Jul 21
 -0.02 / -1.44%
Today’s Change
1.26
Today|||52-Week Range
4.25
-19.88%
Year-to-Date
No recent news for pSivida Corp.

Today’s Trading

Previous close1.39
Today’s open1.38
Day’s range1.36 - 1.41
Volume331,101
Average volume (3 months)624,447
Market cap$53.9M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-423.81%
Earnings growth (this year)+24.51%
Earnings growth (next 5 years)+0.00%
Revenue growth (last year)-93.90%
P/E ratioNM
Price/Sales55.24
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
AKTXAkari Therapeutics P...-0.06-1.28%
CODXCo-Diagnostics Inc-0.29-5.95%
CFRXContraFect Corp-0.10-7.41%
KMPHKemPharm Inc-0.10-2.78%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateSeptember 12, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$1.6M
Annual profit (last year)-$21.5M
Net profit margin-1,330.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nancy Sue Lurker
Vice President-
Operations
Marty Nazzaro
Corporate headquarters
Watertown, Massachusetts

Forecasts